A Rare Cause of Bacteremia in a Pediatric Patient with Down Syndrome: Sphingomonas Paucimobilis

Basit Öğe Kaydı
dc.contributor.authorOzdemir, Mehmet
dc.contributor.authorPekcan, Sevgi
dc.contributor.authorDemircili, Mehmet Emin
dc.contributor.authorTasbent, Fatma Esenkaya
dc.contributor.authorFeyzioglu, Bahadir
dc.contributor.authorPirinc, Serife
dc.contributor.authorBaykan, Mahmut
dc.date.accessioned2020-03-26T18:13:41Z
dc.date.available2020-03-26T18:13:41Z
dc.date.issued2011
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractSphingomonas paucimobilis, is a yellow-pigmented, aerobic, non fermentative, gram negative motile bacillus. S. paucimobilis which is widely found in nature and hospital environments rarely cause serious or life threatening infections. In this report, a case of hospital acquired bloodstream infection due to S. paucimobilis in a patient with Down syndrome who was on treatment for presumed pneumonia is presented. A one year-old child patient who was a known case of Down syndrome and had previously experienced cardiac surgery was hospitalized and treated for pneumonia. On the 12th day of hospitalization, blood cultures were taken because of a high body temperature. One of the blood cultures was positive for gram-negative rods. After 48 hour of incubation, the sub-cultures on blood agar medium yielded pure growth of a yellow, non-fermentative, gram-negative, rod-shaped bacterium. The microorganism was positive for oxidase, and esculin hydrolysis, while negative for urea and nitrate reduction, citrate utilisation and motility. The isolate had been identified as S. paucimobilis by using Vitek 2 system. The antibiotic susceptibility test was also performed with the same system and the strain was found to be susceptible to piperacillin-tazobactam and other antibiotics. Treatment with intravenous piperacilin-tazobactam (150 mg/kg/day) was initiated. He responded well to the treatment and was discharged after 10 days. This case is reported to emphasize that S. paucimobilis should be kept in mind as a nosocomial infectious agent in patients with Down syndrome and immunosuppressive patients and the infections should be treated according to the sensitivity test results.en_US
dc.identifier.endpage539en_US
dc.identifier.issn1449-1907en_US
dc.identifier.issue7en_US
dc.identifier.pmid21960744en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage537en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/26072
dc.identifier.volume8en_US
dc.identifier.wosWOS:000298011800004en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherIVYSPRING INT PUBLen_US
dc.relation.ispartofINTERNATIONAL JOURNAL OF MEDICAL SCIENCESen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectSphingomonas paucimobilisen_US
dc.subjectbacteriemiaen_US
dc.subjecthospitalen_US
dc.subjectinfectionen_US
dc.subjectDown syndromeen_US
dc.titleA Rare Cause of Bacteremia in a Pediatric Patient with Down Syndrome: Sphingomonas Paucimobilisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu